Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S ( (DE:2TZ) ) just unveiled an announcement.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited has announced an online conference to discuss its financial results for the fiscal year 2024 and the three-month period ending March 31, 2025. The conference aims to provide investors with a comprehensive understanding of the company’s performance and will be held on June 11, 2025, via a remote network interaction platform.
More about Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited, is a company incorporated in the People’s Republic of China. It operates within the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products.
See more data about 2TZ stock on TipRanks’ Stock Analysis page.